KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to 0.19.

  • Pacific Biosciences Of California's Asset Utilization Ratio rose 6223.79% to 0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19, marking a year-over-year increase of 6223.79%. This contributed to the annual value of 0.1 for FY2024, which is 1024.98% down from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Asset Utilization Ratio is 0.19, which was up 6223.79% from 0.19 recorded in Q2 2025.
  • Pacific Biosciences Of California's Asset Utilization Ratio's 5-year high stood at 0.19 during Q3 2025, with a 5-year trough of 0.06 in Q4 2021.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.09 (2023), whereas its average is 0.1.
  • Per our database at Business Quant, Pacific Biosciences Of California's Asset Utilization Ratio plummeted by 7698.57% in 2021 and then skyrocketed by 6223.79% in 2025.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Asset Utilization Ratio stood at 0.06 in 2021, then increased by 10.78% to 0.07 in 2022, then surged by 53.78% to 0.11 in 2023, then rose by 3.27% to 0.11 in 2024, then soared by 67.04% to 0.19 in 2025.
  • Its Asset Utilization Ratio was 0.19 in Q3 2025, compared to 0.19 in Q2 2025 and 0.14 in Q1 2025.